Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising results. However, the price of this innovative drug and its availability have become key topics for patients and healthcare practitioners. While tirzepatide has been authorized by regulatory agencies, its high-priced nature presents a significant barrier